Kan and Krishme successfully represents patentee in landmark post-grant opposition against Indian pharmaceutical companies: Introduction The Indian Patent Office (IPO) has upheld Indian Patent No. 315447 in favor of Celator Pharmaceuticals Inc., dismissing post-grant oppositions filed by Cipla Ltd. and Mylan Laboratories Ltd. This landmark ruling affirms the strength of Celator’s patent covering its novel […]